What is Evommune 's equity method income?

Evommune (EVMN) reported equity method income of $77.05K in Q1 2026.

What does equity method income mean?

The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.

Evommune EVMN Equity Method Income

Equity Method Income at other companies

Cabot CorporationCBT

$2M-33.3%

HES

Hess MidstreamHESM

$3.2M-5.9%

Ryan Specialty HoldingsRYAN

$5.53M+12.0%

Liberty Broadband CorporationLBRDK

$308M-3.1%

Atmus Filtration TechnologiesATMU

$7.6M-17.4%

PBF EnergyPBF

$8.3M+149%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's equity method income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's equity method income?: Evommune (EVMN) reported equity method income of $77.05K in Q1 2026.
What does equity method income mean?: The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.